Background : Multiple sclerosis (MS) is one of the most common neurological diseases in humans, impacting the psychological and social dimensions of affected individuals, including their hope and resilience. Therefore, the present study aimed to determine the effectiveness of dialectical behavior therapy on the hope and resilience of patients with multiple sclerosis. Methods: This semi-experimental research used a pretest-posttest design with a control group and a follow-up period. The study population included MS patients residing in Tehran, members of the MS Association of Iran, and patients visiting neurologists' clinics in Tehran during the second half of 2023, all of whom had been diagnosed by neurologists. From eligible individuals, 30 patients were selected through purposive sampling and randomly assigned to two groups (15 in the experimental group and 15 in the control group) using a simple random method (placing even and odd balls in a box). Data collection tools included the Hope Scale by Snyder et al. (1991) and the Connor-Davidson Resilience Scale (2003). The intervention group participated in twelve 90-minute group sessions over two months, while the control group received routine care. Data were analyzed using SPSS version 22 and repeated measures analysis of variance, with adherence to statistical assumptions. Results: The findings indicated significant differences in the mean scores of hope and resilience of MS patients in the post-test and follow-up phases compared to the pre-test phase, with these results remaining stable through the follow-up period (P < 0.01). Thus, dialectical behavior therapy improved the hope and resilience of MS patients. Conclusion: Based on the results of this study, dialectical behavior therapy can be considered an effective therapeutic approach to improving the health and psychological well-being of patients with multiple sclerosis.
mouri S, khalatbari J, fath abadi J, Ghorban Shiroodi S, sabet M. The Effectiveness of Dialectical Behavior Therapy on the Hope and Resilience of Patients with Multiple Sclerosis. IJNR 2025; 19 (6) :63-72 URL: http://ijnr.ir/article-1-2955-en.html